ABSTRACr The inhibitory function of a, antitrypsin (a,AI) has been studied in the lung secre-tions of 31 patients with chronic obstructive bronchitis. The inhibitory capacity for a single sample showed a wide range (median 0O13 ,ug porcine pancreatic elastase (PPE) inhibited per ,ug a, antitrypsin; range 0-O 55 ,ug), and all but five of 86 samples studied were capable of inhibiting some porcine pancreatic elastase. No sample showed free elastase activity, however. The inhibitory capacity, studied in six patients over five consecutive days, varied daily within the same individual (coefficient of variation 9.0-108-9%). Corticosteroid treatment (40 mg prednisone daily) increased the inhibitory capacity of sputum a, antitrypsin in 10 patients (2p < 0 05) from a median value of 0-13 ug PPE inhibited per jig a,AT (range 0 06-0 36) before treatment to 0 22 ,ug PPE inhibited per ,ug a,AT (range 0.09-0.65) after treatment. The inhibitory capacity of sputum was higher than in the corresponding bronchoalveolar lavage sample from the same patient (2p < 005; n = 10). The median value for sputum was 0-22 ug PPE inhibited per ug a,AT (range 0-0.55) and the value for lavage fluid was 0 07 ,ug PPE inhibited per ,ug a,AT (range 0-0.27).
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The demonstration that intratracheal instillation of a proteolytic enzyme (papain) in rats produced emphysema' led to the idea that proteinases are important in the pathogenesis of emphysema. Elastases are capable of digesting lung elastin,2 and human leucocyte elastase has been shown to damage bronchial mucosa and ciliated epithelium,3 and to cause emphysema in experimental animals. 4 It has been suggested therefore that leucocyte elastase may also play a part in the pathogenesis of cystic fibrosis,5 bronchiectasis,6 and the adult respiratory distress syndrome' as well as emphysema.
The action of proteolytic enzymes is opposed in vivo by several proteinase inhibitors. Of Sputum samples were collected over a three to four hour period in the morning and then ultracentrifuged at 50 000 g for 90 minutes (3°C). The sol phase was removed and stored at -70°C until it was analysed.
EFFECT OF DRUGS
Eleven patients were studied on a single day before and on the sixth day after starting a course of prednisone, 40 mg daily. The procedure has been described in detail previously. '4 Briefly, sputum that had been collected on the morning of one of the control days (chosen by the presence of adequate samples to study the maximum number of patients) was compared with samples from the same 11 patients collected on the sixth day of steroid treatment, when the greatest changes in protein concentrations had been seen. '4 Ten further patients were studied, from whom sputum samples were collected on a pretreatment control day and on the seventh day of treatment with bromhexine, 32 mg daily.
All samples were processed as described above.
COMPARISON OF SPUTUM WITH BRONCHOALVEOLAR LAVAGE FLUID
Ten patients undergoing diagnostic fibreoptic bronchoscopy for suspected pulmonary neoplasia or unexplained haemoptysis were studied. Sputum was collected before premedication with atropine and processed as described above. After administration of intravenous diazepam and local anaesthesia with intranasal and nasopharyngeal lignocaine, the bronchoscope was passed through the nose and the vocal cords were then anaesthetised with two 2 ml aliquots of 4% lignocaine. further, we adsorbed a1AT from one of the three samles using a sepharose bound anti-a,AT antibody immunoadsorption column. After the main protein peak (peak 1) had passed through the column the adsorbed protein (peak 2) was eluted with 0-2 mol/I glycine hydrochloride, pH 2 5, and then dialysed against 0-2 mol/l tris hydrochloride, pH 8-6. The protein containing samples were tested immunologically for the presence of a,AT to ensure that a,AT was excluded from the main peak (peak 1) and the OLAT was present in the eluted fractions (peak 2). The fractions containing the main protein peak were pooled, as were those from peak 2 which contained the previously adsorbed protein. The pooled fractions were concentrated 20-30 fold as described for the bronchoalveolar lavage fluid samples and tested for inhibitory activity towards PPE. Only the fractions containing a,AT (peak 2) showed any inhibition ( fig 2) .
Discussion
Despite the presumed importance of a, antitrypsin in protecting the lung from damage by proteolytic enzymes, there have been very few studies of the variability in the functional capacity of a, antitrypsin and these have been performed on bronchoalveolar lavage fluid obtained from normal subjects at irregular intervals over several months. 2' 22 In the present study we have assessed the short term variability in secretions from the upper part of the lower respiratory tract from several patients over five consecutive days.
The within subject variation of inhibitory capacity differed for each patient and was occasionally large. The reason for this wide variation is not clear. All the patients were current smokers, but the variations in the cigarettes they smoked in a day during the period of study may The effect of drugs is of interest. In our previous studies the concentration of a, antitrypsin in sputum tended to fall in patients having steroids,'4 perhaps owing to a decrease in protein transudation from serum as part of the general anti-inflammatory effect of corticosteroids. Despite this, the inhibitory function of a, antitrypsin improved in that these secretions were able to inhibit more porcine pancreatic elastase per p.g a,AT. This would suggest that although the lung a, antitrypsin has fallen there has been a greater fall in the proteinase burden, perhaps owing to a reduction in proteinase bearing cells (such as neutrophils and macrophages) or a decrease in release of proteinase due to stabilisation of lysosomal membranes.23 Whether such changes could be advantageous either in the short term or over periods of years by having a beneficial effect on the lung proteinase-antiproteinase balance remains to be determined. Bromhexine treatment in the dosage used seemed to have no effect on the inhibitory capacity of a, antitrypsin in the lung. No attempt was made to determine whether a true mucolytic action occurred.
Three sputum samples inhibited more porcine pancreatic elastase than could be accounted for by the a, antitrypsin present as measured immunologically. A similar slight discrepancy has been noted by Carp et a12' in their studies of bronchoalveolar lavage fluid from 24 non-smokers. They obtained an inhibition of 0 59 + 0X08 ,ug PPE per ,ug a,AT (the theoretical value should be 0-5 ug PPE inhibited per ,ug a,AT) and thought that this discrepancy was due to impurities in the commercially prepared porcine pancreatic elastase. The interpretation of these slight discrepancies is also dependent on several other factors. Firstly, accurate quantification of lung a, antitrypsin is imperative and we have previously indicated that such inaccuracies are likely to occur even with the best polyclonal antisera. '6 Immunological errors in estimation, however, are likely to occur only if tie a, antitrypsin has been inactivated as an inhibitor and would therefore be unlikely to account for the apparent overestimation of a, antitrypsin inhibitory function. Secondly, the observation could also be explained by the presence of another inhibitor of porcine pancreatic elastase in the sputum or bronchoalveolar lavage fluid that was contributing to the total elastase inhibition screen; but, despite a decade of research on this subject, a, antitrypsin and a2 macroglobulin are the only inhibitors present in sputum which have been shown to be active against porcine pancreatic elastase in stable chronic obstructive bronchitis. Although Hochstrasser et al have recently demonstrated the Morrison, Afford, Stockley presence of another inhibitor of porcine pancreatic elastase in sputum, it has to be activated by acidification and is inactive in the stable clinical state.20
Alpha2 macroglobulin is capable of causing partial inhibition of porcine pancreatic elastase activity against small peptide substrates such as Succ(Ala) 3pNA,24 but it is present only in low concentrations in sputum (usually less than 5% of the a, antitrypsin molar concentration'0) and it is thus likely to contribute little if anything to the inhibition of the enzyme in the present studies. In view of these studies most research groups, including Boudier et al in their recent study,25 have used methods similar to those described here to determine a, antitrypsin function in secretions.
The use of the immunoadsorption column to fractionate one of the sputum samples with greater inhibitory capacity for porcine pancreatic elastase than could be accounted for by the a, antitrypsin present confirmed that all inhibition of the commercially prepared enzyme resided in the protein peak containing a, antitrypsin. This suggests that the discrepancy between the expected and observed inhibition of porcine pancreatic elastase is likely to be a result of minor impurities in the commercially prepared enzyme, as suggested previously by Carp et al, 2' and not due to the presence of another inhibitor of the elastase.
In contrast to these three sputum samples, one paired sputum and bronchoalveolar lavage sample and one additional sputum and two additional bronchoalveolar lavage samples failed to inhibit any porcine pancreatic elastase, despite the presence of easily measurable quantities of a, antitrypsin in the secretions. The inactivation may be related to cigarette smoking, although other samples from this group of smoking patients, with similar amounts of a, antitrypsin (as estimated by rocket immunoelectrophoresis), were able to inhibit the enzyme. The amount of leucocyte elastase present in these samples and the degree of enzyme-inhibitor complexing and partial proteolysis of a, antitrypsin were not estimated, so it is uncertain whether one of these other factors or oxidation or a combination of them was responsible for the observed result.
Variation in the inhibitory capacity of a, antitrypsin between patients was also large. Strict comparison of our results with those of other workers is difficult, since results are usually expressed as means and standard deviations and this is probably inappropriate for most of our results, which do not show a normal distribution. In samples from our paired sputum and bronchoalveolar lavage fluid study the average inhibitory capacity was 0-24 (0.18) ,mg PPE4g a,AT for sputum and 0O10 (0.10) for lav-age fluid. This result would give coefficients of variation of 75% and 100% respectively. Although these within patient variabilities are similar they are clearly greater than the coefficient of variation for lavage fluid from smokers obtained by Carp and his coworkers2'-namely 13 6%. The difference may be due to the selection of patients since the current results are from patients with established lung disease and those of Carp et al are from normal subjects. Similar reasons may account for the relatively constant results obtained from normal subjects studied by Carp et al on different occasions, which contrast with the appreciable variability found in some of our patients.
The inhibitory capacity of a, antitrypsin in bronchoalveolar lavage fluid was less than that found in sputum from the same subject. The reasons for this finding are not clear. Possibly drugs given at the time of bronchoscopy could play a part, although only atropine and diazepam were used systemically, 30 and five minutes respectively, before the procedure. Although we have shown that lignocaine instilled into the area to be lavaged does not affect a, antitrypsin function in vitro (unpublished observations), it could cause cellular disruption and release of some proteinase during the lavage procedure, which does not occur during sputum collection. Alternatively, the difference in the inhibitory capacity of a, antitrypsin might be due to differences in the local environment and cells found at bronchoalveolar and at bronchial level. In this context the preponderance of macrophages at bronchoalveolar level may be important since it is known that macrophage elastase can inactivate a, antitrypsin.26 Further studies will be necessary before clear conclusions can be drawn.
In conclusion, we have shown that the variability of al antitrypsin inhibitory capacity in sputum, both between and within patients, is large. Steroids alter the inhibitory capacity of a1 antitrypsin in sputum and this may have long term implications affecting the management of patients with proteinase related lung disease. Bromhexine had no effect on the inhibitory capacity. Finally, the ability of a, antitrypsin to inhibit proteinases is lower in bronchoalveolar lavage fluid than in sputum, although the reason for this is not clear.
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